What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Immune system
His primary scientific interests are in Molecular biology, Chronic lymphocytic leukemia, Immunology, B cell and Leukemia.
His Molecular biology research is multidisciplinary, incorporating perspectives in Receptor, Antibody, Genetics and Gene rearrangement.
His studies deal with areas such as Signal transduction and Cell growth as well as Chronic lymphocytic leukemia.
His [email protected] study in the realm of Immunology interacts with subjects such as CD38.
The various areas that Manlio Ferrarini examines in his [email protected] study include Monoclonal B-cell lymphocytosis and Oncology.
To a larger extent, Manlio Ferrarini studies Internal medicine with the aim of understanding Leukemia.
His most cited work include:
- Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. (2241 citations)
- Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. (2241 citations)
- Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. (2241 citations)
What are the main themes of his work throughout his whole career to date?
Manlio Ferrarini focuses on Chronic lymphocytic leukemia, Immunology, Molecular biology, Internal medicine and Cancer research.
In the field of Chronic lymphocytic leukemia, his study on [email protected] overlaps with subjects such as CD38.
His work on Immunology is being expanded to include thematically relevant topics such as In vitro.
The Molecular biology study combines topics in areas such as Cell culture, CD40, Antibody, B cell and Receptor.
His Internal medicine research integrates issues from Gastroenterology and Oncology.
His biological study spans a wide range of topics, including Framingham Risk Score and Gene mutation.
He most often published in these fields:
- Chronic lymphocytic leukemia (42.61%)
- Immunology (38.49%)
- Molecular biology (30.24%)
What were the highlights of his more recent work (between 2011-2021)?
- Chronic lymphocytic leukemia (42.61%)
- Internal medicine (26.12%)
- Oncology (16.15%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Chronic lymphocytic leukemia, Internal medicine, Oncology, [email protected] and Immunology.
His study with Chronic lymphocytic leukemia involves better knowledge in Leukemia.
In his study, which falls under the umbrella issue of Leukemia, In vivo is strongly linked to Pathology.
His Oncology research incorporates themes from Framingham Risk Score, Bendamustine, Rituximab and MEDLINE.
His study in [email protected] is interdisciplinary in nature, drawing from both Gene expression profiling, Trisomy, Monoclonal B-cell lymphocytosis, Gene and Disease.
His Immunology study integrates concerns from other disciplines, such as Mutational status and Downregulation and upregulation.
Between 2011 and 2021, his most popular works were:
- Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence (174 citations)
- miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone disease. (143 citations)
- miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1 (123 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Manlio Ferrarini mostly deals with Chronic lymphocytic leukemia, [email protected], Immunology, Cancer research and Internal medicine.
The various areas that Manlio Ferrarini examines in his Chronic lymphocytic leukemia study include Mutation, Receptor, Disease and Binding site.
His work carried out in the field of [email protected] brings together such families of science as Polymerase chain reaction, Cancer staging and Late onset.
His research integrates issues of Trisomy and Retrospective cohort study in his study of Immunology.
His work on Stromal cell as part of general Cancer research study is frequently connected to CD38, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
The study incorporates disciplines such as Hypogammaglobulinemia and Oncology in addition to Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
